1. Ahmad Z, Wardale J, Brooks R, Henson F, Noorani A, Rushton N. Exploring the application of stem cells in tendon repair and regeneration. Arthroscopy (2012) 28:1018–29.10.1016/j.arthro.2011.12.009.
  2. Akari Sasaki, Mitsuru Mizuno, Manabu Mochizuki. Mesenchymal stem cells for cartilage regeneration in dogs Ichiro Sekiya Cells. World J Stem May 26, 2019; 11(5): 254-269. doi: 10.4252/wjsc.v11.i5.254.
  3. Angelone M, Conti V, Biacca C, et al. The Contribution of Adipose Tissue-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma to the Treatment of Chronic Equine Laminitis: A Proof of Concept. Int J Mol Sci. 2017;18(10):2122. Published 2017 Oct 11. doi:10.3390/ijms18102122.
  4. Antonio J. Villatoro Jiménez, Fernando Fariñas Guerrero Células madre mesenquimales como nueva terapia en dermatología: conceptos básicos. ImmuneStem, Instituto de Inmunología Clínica y Terapia Celular, Málaga, España.
  5. Arend CF, Arend AA, Silva TR. Diagnostic value of tendon thickness and structure in the sonographic diagnosis of supraspinatus tendinopathy: room for a two-step approach. Eur J Radiol (2014) 83:975–9.10.1016/j.ejrad.2014.02.021.
  6. Arzi B, Clark K, Sundaram A. Therapeutic efficacy of fresh, allogeneic mesenchymal stem cells for severe refractory Gingivostomatitis in Cats. Stem Cells Transl Med. 2017;6:1710–22.
  7. Ascheim DD, Gelijns AC, Goldstein D, et al. Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices. Circulation. 2014;129 (22):2287–2296. doi:10.1161/CIRCULATIONAHA.113.007412.
  8. Au KK, Gordon-Evans WJ, Dunning D, O’Dell-Anderson KJ, Knap KE, Griffon D, et al. Comparison of short- and long-term function and radiographic osteoarthrosis in dogs after postoperative physical rehabilitation and tibial plateau leveling osteotomy or lateral fabellar suture stabilization. Vet Surg (2010) 39:173–80.10.1111/j.1532-950X.2009.00628.x.
  9. Bavin EP, Smith O, Baird AEG, Smith LC, Guest DJ. Equine induced pluripotent stem cells have a reduced tendon differentiation capacity compared to embryonic stem cells. Front Vet Sci. 2015;2:55.
  10. Behr L, Hekmati M, Lucchini A, Houcinet K, Faussat AM, Borenstein N, Noel LH, Lelievre-Pegorier M, Laborde K. Evaluation of the effect of autologous mesenchymal stem cell injection in a large-animal model of bilateral kidney ischaemia reperfusion injury. Cell Prolif. 2009;42(3):284–297.
  11. Belknap J.K., Faleiros R., Black S.J., Johnson P.J., Eades S. The laminar leukocyte: From sepsis to endocrinopathic models of laminitis. J. Vet. Sci. 2011;31:584–585. doi: 10.1016/j.jevs.2011.09.034.
  12. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure–definition, outcome measures, animal models, fluid therapy and information technology needs: The second international consensus conference of the acute dialysis quality initiative (adqi) group. Crit care. 2004;8(4):R204.
  13. Ben-Ami E, Berrih-Aknin S, Miller A. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. Autoimmun Rev. (2011) 10:410–5. doi: 10.1016/j.autrev.2011.01.005.
  14. Berg L, Koch T, Heerkens T, Bessonov K, Thomsen P and Betts D. (2009). Chondrogenic potential of mesenchymal stromal cells derived from equine bone marrow and umbilical cord blood. Vet Comp Orthop Traumatol 22:363–370.
  15. Black LL, Gaynor J, Gahring D, Adams C, Aron D, Harman S, Gingerich DA, Harman R. Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet Ther. 2007;8(4):272-284.
  16. Bodderker J, Druen S, Meyer-Lindenberg A, Fehr M, Nolte I, Wefstaedt P. Computer-assisted gait analysis of the dog: comparison of two surgical techniques for the ruptured cranial cruciate ligament. Vet Comp Orthop Traumatol (2012) 25:11–21.10.3415/VCOT-10-02-0025.
  17. Borjesson DL, Peroni JF. The regenerative medicine laboratory: facilitating stem cell therapy for equine disease. Clin Lab Med. (2011) 31:109–23. doi: 10.1016/j.cll.2010.12.001.
  18. Broeckx S, Suls M, Beerts C, Vandenberghe A, Seys B, Wuertz-Kozak K, Duchateau L and Spaas JH. (2014). Allogenic mesenchymal stem cells as a treatment for equine degenerative joint disease: a pilot study. Curr Stem Cell Res Ther 9:497–503.
  19. Broeckx S, Zimmerman M, Crocetti S, Suls M, Mariën T, Ferguson SJ, Chiers K, Duchateau L, Franco-Obregón A, Wuertz K and Spaas JH. (2014). Regenerative therapies for equine degenerative joint disease: a preliminary study. PLoS One 9:e85917.
  20. Broeckx SY, Seys B, Suls M, et al. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses. Stem Cells Dev. 2019;28(6):410–422. doi:10.1089/scd.2018.0061.
  21. Brose SW, Boninger ML, Fullerton B, McCann T, Collinger JL, Impink BG, et al. Shoulder ultrasound abnormalities, physical examination findings, and pain in manual wheelchair users with spinal cord injury. Arch Phys Med Rehabil (2008) 89:2086–93.10.1016/j.apmr.2008.05.015.
  22. Cai Y, Zou Z, Liu L, Chen S, Chen Y, Lin Z, et al. Bone marrow-derived mesenchymal stem cells inhibits hepatocyte apoptosis after acute liver injury. Int J Clin Exp Pathol. 2015;8:107–116.
  23. Canapp SO Jr, Canapp DA, Ibrahim V, Carr BJ, Cox C, Barrett JG. The Use of Adipose-Derived Progenitor Cells and Platelet-Rich Plasma Combination for the Treatment of Supraspinatus Tendinopathy in 55 Dogs: A Retrospective Study. Front Vet Sci. 2016;3:61. Published 2016 Sep 9. doi:10.3389/fvets.2016.00061.
  24. Canapp SO Jr, Leasure CS, Cox C, Ibrahim V, Carr BJ. Partial Cranial Cruciate Ligament Tears Treated with Stem Cell and Platelet-Rich Plasma Combination Therapy in 36 Dogs: A Retrospective Study. Front Vet Sci. 2016;3:112. Published 2016 Dec 14. doi:10.3389/fvets.2016.00112.
  25. Canapp SO. Supraspinatus tendinopathy in dogs. Proceedings ACVS Symposium San Antonio, TX (2013).
  26. Canapp, SO, Canapp, DA, Carr, BJ, Cox, C. & Barrett, JG (2016). Supraspinatus Tendinopathy in 327 dogs: a retrospective study.
  27. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98(5):1076–84.
  28. Carrade DD, Borjesson DL. Immunomodulation by mesenchymal stem cells in veterinary species. Comp Med. (2013) 63:207–17.
  29. Chen L, Tredget EE, Wu PY, et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008;3:e1886.
  30. Chen SL, Fang WW, Qian J, Ye F, Liu YH, Shan SJ, Zhang JJ, Lin S, Liao LM, Zhao RC. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymalstemcellsinpatientswithacutemyocardialinfarction.ChinMedJ 117: 1443–1448, 2004.
  31. Chong JJ, Chandrakanthan V, Xaymardan M, Asli NS, Li J, Ahmed I, Heffernan C, Menon MK, Scarlett CJ, Rashidianfar A, Biben C, Zoellner H, Colvin EK, Pimanda JE, Biankin AV, Zhou B, Pu WT, Prall OW, Harvey RP. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 9: 527–540, 2011.
  32. Chong JJ, Chandrakanthan V, Xaymardan M, et al. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell. 2011;9(6):527–540. doi:10.1016/j.stem.2011.10.002.
  33. Christina McKeea, Naimisha Beeravolua, Christina Browna, Mick Perez-Cruet, G. Rasul Chaudhrya, Mesenchymal stem cells transplanted with self-assembling scaffolds differentiated to regenerate nucleus pulposus in an ex vivo model of degenerative disc disease Applied Materials Today Volume 18, March 2020, 100474.
  34. Chugh AR, Beache GM, Loughran JH, et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation. 2012;126(11 Suppl 1):S54–S64. doi:10.1161/CIRCULATIONAHA.112.092627.
  35. Chung CB, Gentili A, Chew FS. Calcific tendinosis and periarthritis: classic magnetic resonance imaging appearance and associated findings. J Comput Assist Tomogr (2004) 28:390–6.10.1097/00004728-200405000-000158.
  36. Contino EK. (2018). Management and rehabilitation of joint disease in sport horses. Vet Clin North Am Equine Pract 34:345–358.
  37. Cuervo B, Rubio M, Sopena J, et al. Hip osteoarthritis in dogs: a randomized study using mesenchymal stem cells from adipose tissue and plasma rich in growth factors. Int J Mol Sci. 2014;15(8):13437-13460. doi: 10.3390/ijms150813437.
  38. L. Williams, “Immunopathogenesis of Keratoconjunctivitis sicca in the dog,” Veterinary Clinics of North America: Small Animal Practice, vol. 38, no. 2, pp. 251–268, 2008.
  39. D’UvaG,AharonovA,LauriolaM,KainD,Yahalom-RonenY,CarvalhoS,Weisinger K, Bassat E, Rajchman D, Yifa O, Lysenko M, Konfino T, Hegesh J, Brenner O, NeemanM,YardenY,LeorJ,SarigR,HarveyRP,TzahorE.ERBB2triggersmammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. Nature Cell Biol 17: 627–638, 2015.
  40. Danova NA, Muir P. Extracorporeal shock wave therapy for supraspinatus calcifying tendinopathy in two dogs. Vet Rec (2003) 152:208–9.10.1136/vr.152.7.208.
  41. de Grauw JC, Visser-Meijer MC, Lashley F, Meeus P and van Weeren PR. (2016). Intra-articular treatment with triamcinolone compared with triamcinolone with hyaluronate: A randomised open-label multicentre clinical trial in 80 lame horses. Equine Vet J 48:152–158.
  42. de Mattos Carvalho A, Alves A L, Golim M A, et al. 2009. Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue[J]. Veterinary Immunology and Immunopathology, 132: 303-306.
  43. Dean BJF, Franklin SL, Carr AJ. A systemic review of the histological and molecular changes in rotator cuff disease. Bone Joint Res (2012) 1:158–66.10.1302/2046-3758.17.2000115.
  44. DeLuke AM, Allen DA, Wilson ER, Lineberger JA, Lehenbauer TW, Fabiani M, et al. Comparison of radiographic osteoarthritis scores in dogs less than 24 months or greater than 24 months following tibial plateau leveling osteotomy. Can Vet J (2012) 53:1095–9.
  45. Dias IE, Pinto PO, Barros LC, Viegas CA, Dias IR, Carvalho PP. Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases?. BMC Vet Res. 2019;15(1):358. Published 2019 Oct 22. doi:10.1186/s12917-019-2087-2.
  46. Dias, I.E., Pinto, P.O., Barros, L.C. et al. Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases? BMC Vet Res 15, 358 (2019). https://doi.org/10.1186/s12917-019-2087-2.
  47. Dowers, KL, Hawley, JR, Brewer, MM. Association of Bartonella species, feline cali-civirus, and feline herpesvirus 1 infection with gingivostomatitis in cats. J Feline Med Surg 2010; 12: 314–321.
  48. M.Pérez-Merinoa, J.M.Usón-Casaúsa, C.Zaragoza-Baylea, J.Duque-Carrascob, L Mariñas-Pardoc, M.Hermida-Prietoc, R.Barrera-Chacóna, M.Gualtierid Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Endoscopic and histological outcomes. The Veterinary Journal 206(3):391-397.
  49. Eades S.C. Overview of current laminitis research. Vet. Clin. North Am. Equine Pract. 2010;26:51–63. doi: 10.1016/j.cveq.2010.01.001.
  50. Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014;6:265sr6. doi: 10.1126/scitranslmed.3009337.
  51. Enciso N, Avedillo L, Fermín ML, Fragío C, Tejero C. Regenerative potential of allogeneic adipose tissue-derived mesenchymal cells in canine cutaneous wounds. Acta Vet Scand. 2020;62(1):13. Published 2020 Mar 12. doi:10.1186/s13028-020-0511-z.
  52. Escalhão CCM, Ramos IP, Hochman-Mendez C, et al. Safety of Allogeneic Canine Adipose Tissue-Derived Mesenchymal Stem Cell Intraspinal Transplantation in Dogs with Chronic Spinal Cord Injury. Stem Cells Int. 2017;2017:3053759. doi:10.1155/2017/3053759.
  53. Ettinger SJ. Textbook of veterinary internal medicine. 8. Missouri: Elsevier; 2017.
  54. Eustace R.A. Clinical presentation, diagnosis, and prognosis of chronic laminitis in Europe. Vet. Clin. North Am. Equine Pract. 2010;26:391–405. doi: 10.1016/j.cveq.2010.06.005.
  55. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366:1736–1743.
  56. Fathke C, Wilson L, Hutter J, et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells. 2004;22:812–822.
  57. FernandesS,ChongJJ,PaigeSL,IwataM,Torok-StorbB,KellerG,ReineckeH,Murry CE. Comparison of human embryonic stem cell-derived cardiomyocytes, cardiovascular progenitors, and bone marrow mononuclear cells for cardiac repair. Stem Cell Reports 5: 753–762, 2015.
  58. Ferrer L, Kimbrel EA, Lam A, Falk EB, Zewe C, Juopperi T, et al. Treatment of perianal fistulas with human embryonic stem cell-derived mesenchymal stem cells: a canine model of human fistulizing Crohn’s disease. Regen Med. 2016;11(1):33-43.
  59. Ferris DJ, Frisbie DD, Kisiday JD, McIlwraith CW, Hague BA, Major MD, Schneider RK, Zubrod CJ, Kawcak CE and Goodrich LR. (2014). Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury. Vet Surg 43:255–265.
  60. Flo GL, Middleton D. Mineralization of the supraspinatus tendon in dogs. J Am Vet Med Assoc (1990) 197:95–9.
  61. Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM and McIlwraith CW. (2009). Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res 27:1675–1680.
  62. Fu Y, Karbaat L, Wu L, Leijten J, Both SK, Karperien M. Trophic effects of mesenchymal stem cells in tissue regeneration. Tissue Eng Part B Rev. (2017) 23:515–28. doi: 10.1089/ten.teb.2016.0365.
  63. Gao J, Caplan AI. Mesenchymal stem cells and tissue engineering for orthopaedic surgery. Chir Organi Mov (2003) 88:305–16.
  64. Gao X, Song L, Shen K, Wang H, Qian M, Niu W, et al. Bone marrow mesenchymal stem cells promote the repair of islets from diabetic mice through paracrine actions. Mol Cell Endocrinol. 2014;388(1–2):41–50.
  65. Gazdic M, Volarevic V, Arsenijevic N, et al. Mesenchymal stem cells: a friend or foe in immune-mediated diseases. Stem Cell Rev 2015;11:280–7.
  66. Gilsanz C, Aller MA, Fuentes-Julian S, Prieto I, Blazquez-Martinez A, Argudo S, et al. Adipose-derived mesenchymal stem cells slow disease progression of acute-on-chronic liver failure. Biomed Pharmacother. 2017;91:776–787. doi: 10.1016/j.biopha.2017.04.117.
  67. Golpanian S, El-Khorazaty J, Mendizabal A, DiFede DL, Suncion VY, Karantalis V, Fishman JE, Ghersin E, Balkan W, Hare JM. Effect of aging on human mesenchymal stemcelltherapyinischemiccardiomyopathypatients.JAmCollCardiol65:125–132, 2015.
  68. Goodrich LR and Nixon AJ. (2006). Medical treatment of osteoarthritis in the horse—a review. Vet J 171:51–69.
  69. Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial [published correction appears in JAMA. 2013 Aug 21;310(7):750. George, Richard [added]; Lardo, Albert [added]]. JAMA. 2012;308(22):2369–2379. doi:10.1001/jama.2012.25321.
  70. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study ofintravenousadulthumanmesenchymalstemcells(prochymal)afteracutemyocardial infarction. J Am Coll Cardiol 54: 2277–2286, 2009.
  71. Harel Z, Bell CM, Dixon SN, McArthur E, James MT, Garg AX, Harel S, Silver S, Wald R. Predictors of progression to chronic dialysis in survivors of severe acute kidney injury: A competing risk study. BMC Nephrol. 2014;15:114.
  72. Harman R, Carlson K, Gaynor J, et al. A Prospective, Randomized, Masked, and Placebo-Controlled Efficacy Study of Intraarticular Allogeneic Adipose Stem Cells for the Treatment of Osteoarthritis in Dogs. Front Vet Sci. 2016; 3: Published 2016 Sep 16. doi:10.3389/fvets.2016.00081.
  73. Hashimoto T, Nobuhara K, Hamada T. Pathologic evidence of degeneration as a primary cause of rotator cuff tear. Clin Orthop Relat Res (2003) 415:111–20.10.1097/01.blo.0000092974.12414.22.
  74. Hatzistergos K E, Hare J M. Rebuildingthe Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. Physiol Rev 96:1127 – 1168,2016. Published June22, 2016; doi:10.1152/physrev.00019.2015.
  75. Hawsawi, Y. M., Al-Zahrani, F., Mavromatis, C. (Harris), Baghdadi, M. A., Saggu, S., & Oyouni, A. A. A. (2018). Stem Cell Applications for Treatment of Cancer and Autoimmune Diseases: Its Promises, Obstacles, and Future Perspectives. Technology in Cancer Research & Treatment. https://doi.org/10.1177/1533033818806910.
  76. HJ Lee, Kang KS, Kang SY, Kim HS, Park SJ, Lee SY, et al. Immunologic properties of differentiated and undifferentiated mesenchymal stem cells derived from umbilical cord blood. J Vet Sci. 2016;17:289–97. doi: 10.4142/jvs.2016.17.3.289.
  77. Huang B, Cheng X, Wang H, Huang W, la Ga HZ, Wang D, et al. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J Transl Med. 2016;14:45. doi: 10.1186/s12967-016-0792-1. 124
  78. Hurt G, Baker CL. Calcific teninitis of the shoulder. Orthop Phys Ther Clin N Am (2003) 34:567–75.10.1016/S0030-5898(03)00089-0.
  79. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientifc review. JAMA. 2002;287(3):360–72.
  80. Janeczko, S, Atwater, D, Bogel, E. The relationship of mucosal bacteria to duodenal histopathology, cytokine mRNA, and clinical disease activity in cats wit h inflammatory bowel disease. Vet Microbiol 2008; 128: 178–193.
  81. Jiménez A, Guerrero F. Células madre mesenquimales como nueva terapia en dermatología: conceptos básicos. Rev clínica dermatología Vet. 2017;9:8-18.
  82. JL, Lee RH and Gregory CA. (2016). Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther 7:125.
  83. Joo HJ, Kim JH, Hong SJ. Adipose Tissue-Derived Stem Cells for Myocardial Regeneration. Korean Circ J. 2017;47(2):151–159. doi:10.4070/kcj.2016.0207.
  84. Karantalis V, DiFede DL, Gerstenblith G, et al. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial. Circ Res. 2014;114(8):1302–1310. doi:10.1161/CIRCRESAHA.114.303180.
  85. Karantalis V, Suncion-Loescher VY, Bagno L, Golpanian S, Wolf A, Sanina C, Premer C, Kanelidis AJ, McCall F, Wang B, Balkan W, Rodriguez J, Rosado M, Morales A, Hatzistergos K, Natsumeda M, Margitich I, Schulman IH, Gomes SA, Mushtaq M, DiFedeDL,FishmanJE,PattanyP,ZambranoJP,HeldmanAW,HareJM.Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy. J Am Coll Cardiol 66: 1990–1999, 2015.
  86. Katz L.M., Bailey S.R. A review of recent advances and current hypotheses on the pathogenesis of acute laminitis. Equine Vet. J. 2012;44:752–761. doi: 10.1111/j.2042-3306.2012.00664.x.
  87. Kim BC, Kim HT, Park SH, et al. Fibroblasts from chronic wounds show altered TGF-β-signaling and decreased TGF-β Type II receptor expression. J Cell Physiol. 2003;195:331–336.
  88. Kim JW, Lee JH, Lyoo YS, Jung DI, Park HM. The effects of topical mesenchymal stem cell transplantation in canine experimental cutaneous wounds. Vet Dermatol. 2013;24(2):242–e53. doi:10.1111/vde.12011.
  89. Kim SS, Song CK, Shon SK, et al. Effects of human amniotic membrane grafts combined with marrow mesenchymal stem cells on healing of full-thickness skin defects in rabbits. Cell Tissue Res. 2009;336:59–66. 170
  90. Klinker MW, Wei CH. Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J Stem Cells 2015;7:556–67.
  91. Kriston-Pál É, Czibula Á, Gyuris Z, et al. Characterization and therapeutic application of canine adipose mesenchymal stem cells to treat elbow osteoarthritis. Can J Vet Res. 2017;81(1):73–78.
  92. Kurpinski K, Lam H, Chu J, Wang A, Kim A, Tsay E, Agrawal S, Schaffer DV, Li S. Transforminggrowthfactor-betaandnotchsignalingmediatestemcelldifferentiation into smooth muscle cells. Stem Cells 28: 734–742, 2010.
  93. Barachetti, A. Rampazzo, C. M. Mortellaro, S. Scevola, and B. C. Gilger, “Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study,” Veterinary Ophthalmology, 2014.
  94. Laitinen OM, Flo GL. Mineralization of the supraspinatus tendon in dogs: a long-term follow-up. J Am Anim Hosp Assoc (2000) 36:262–7.10.5326/15473317-36-3-262.
  95. Le Blanc K, Davies LC. Mesenchymal stromal cells and the innate immune response. Immunol Lett. (2015) 168:140–6. doi: 10.1016/j.imlet.2015.05.004.
  96. Ledecky V, Hluchy M, Freilichman R, Hornak S, Knazovicky D. Clinical comparison and short-term radiographic evaluation of tight rope and lateral suture procedures for dogs after cranial cruciate ligament rupture. Vet Med (2014) 59:502–5.
  97. Lee SJ, Ryu MO, Seo MS, et al. Mesenchymal Stem Cells Contribute to Improvement of Renal Function in a Canine Kidney Injury Model. In Vivo. 2017;31(6):1115–1124. doi:10.21873/invivo.11177.50.
  98. Li J, Xin J, Hao S, Zhang L, Jiang L, Chen D, et al. Return of the metabolic trajectory to the original area after human bone marrow mesenchymal stem cell transplantation for the treatment of fulminant hepatic failure. J Proteome Res. 2012;11:3414–3422. doi: 10.1021/pr3002639.
  99. Lineberger JA, Allen DA, Wilson ER, Tobias TA, Shaiken LG, Shiroma J, et al. Comparison of radiographic arthritic changes associated with two variations of tibial plateau leveling osteotomy. A retrospective clinical study. Vet Comp Orthop Traumatol (2005) 18:13–7. 115
  100. Liu WH, Song FQ, Ren LN, Guo WQ, Wang T, Feng YX, et al. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases. J Cell Mol Med. 2015;19:511–520. doi: 10.1111/jcmm.12482.
  101. Loffredo FS, Steinhauser ML, Gannon J, Lee RT. Bone marrow-derived cell therapy stimulatesendogenouscardiomyocyteprogenitorsandpromotescardiacrepair.Cell Stem Cell 8: 389–398, 2011.
  102. B. Abelson, G. W. Ousler III, and C. Maffei, “Dry eye in 2008,” Current Opinion in Ophthalmology, vol. 20, no. 4, pp. 282–286, 2009. doi: 10.1097 / ICU.0b013e32832b7578. 100
  103. Mo, S. Wang, Y. Zhou, H. Li, Y. Wu Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential Cell Mol Life Sci, 73 (17) (2016), pp. 3311-3321.
  104. MacDonald ES, Barrett JG. The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses. Front Vet Sci. 2020;6:507. Published 2020 Jan 21. doi:10.3389/fvets.2019.00507.
  105. Malhotra S, Hu MS, Marshall CD, Leavitt T, Cheung AT, Gonzalez JG, et al. Mesenchymal Stromal Cells as Cell-Based Therapeutics for Wound Healing. Stem Cells Int. 2016;2016:4157934.
  106. Malliaras K, Zhang Y, Seinfeld J, Galang G, Tseliou E, Cheng K, Sun B, Aminzadeh M, Marban E. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeuticregenerationaftermyocardialinfarctionintheadultmouseheart.EMBO Mol Med 5: 191–209, 2013.
  107. Malone ED. (2002). Managing chronic arthritis. Vet Clin North Am Equine Pract 18:411–437.
  108. Manske RC. Tendinopathy. In: Giangarra CE, Manske RC, editors. Clinical orthopaedic rehabilitation: a team approach. 4th ed: Elsevier Health Sciences; 2018. p. 601–4. https://doi.org/10.1016/B978/-0-323-39370-6.00084-6.
  109. MarelliD,DesrosiersC,el-AlfyM,KaoRL,ChiuRC.Celltransplantationformyocardial repair: an experimental approach. Cell Transplant 1: 383–390, 1992.
  110. Marx C, Silveira MD, Nardi NB. Adipose-Derived Stem Cells in Veterinary Medicine: Characterization and Therapeutic Applications Isolation and Characterization of Adipose-Derived Stem Cells. Stem Cells Dev. 2015;24(7):803-813; DOI:10.1089/scd.2014.0407.
  111. Matthay M.A., Pati S., Lee J.W. Concise Review: Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction Following Trauma or S Angelone M, Conti V, Biacca C, et al. The Contribution of Adipose Tissue-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma to the Treatment of Chronic Equine Laminitis: A Proof of Concept. Int J Mol Sci. 2017;18(10):2122. Published 2017 Oct 11. doi:10.3390/ijms18102122epsis. Stem Cells. 2017;35:316–324. doi: 10.1002/stem.2551.
  112. McIlwraith CW, Frisbie DD and Kawcak CE. (2012). The horse as a model of naturally occurring osteoarthritis. Bone Joint Res 1:297–309.
  113. McIlwraith CW. (2005). From Arthroscopy to gene therapy—30 years of looking into joints. In: Annual Convention of the AAEP, 3–7 December, Seattle, IVIS: Washington, USA.
  114. McMurray JJ, Pfeffer MA. Heart failure. Lancet 365: 1877–1889, 2005.
  115. Meirelles Lda S, Fontes AM, Covas DT and Caplan AI. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419–427.
  116. Menglei Wang MD, Can Cao MD, Jing Sun MS Xuebiao Peng MD Application of autologous hematopoietic stem cell transplantation for pemphigus Volume56, Issue3, 2017 P. 296-301.
  117. Molsa SH, Hyytiainen HK, Hielm-Bjorkman AK, Laitinen-Vapaavuori OM. Long-term functional outcome after surgical repair of cranial cruciate ligament disease in dogs. BMC Vet Res (2014) 10:266.10.1186/s12917-014-0266-8.
  118. Monsel A., Zhu Y.G., Gennai S., Hao Q., Liu J., Lee J.W. Cell-based therapy for acute organ injury: Preclinical evidence and ongoing clinical trials using mesenchymal stem cells. Anesthesiology. 2014;121:1099–1121. doi: 10.1097/ALN.0000000000000446.
  119. Morgan R., Keen J., McGowan C. Equine metabolic syndrome. Vet. Rec. 2015; 177:173–179. doi: 10.1136/vr.103226.
  120. Nakagawa H, Akita S, Fukui M, et al. Human mesenchymal stem cells successfully improve skin-substitute wound healing. Br J Dermatol. 2005;153:29–36.
  121. Neirinckx V, Cantinieaux D, Coste C, Rogister B, Franzen R, Wislet-Gendebien S. Concise review: Spinal cord injuries: How could adult mesenchymal and neural crest stem cells take up the challenge. Stem Cells. 2014;32(4):829–843.
  122. Nielsen LK, Bracker K, Price LL. Administration of fenoldopam in critically ill small animal patients with acute kidney injury: 28 dogs and 34 cats (2008-2012) J Vet Emerg Crit Care. 2015;25(3):396–404.
  123. Nizolek DJ and White KK. (1981). Corticosteroid and hyaluronic acid treatments in equine degenerative joint disease. A review. Cornell Vet 71:355–375.
  124. Nourissat G, Berenbaum F, Duprez D. Tendon injury: from biology to tendon repair. Nat Rev Rheumatol. 2015;11:223.
  125. O'Brien EJO, Smith RKW. Mineralization can be an incidental ultrasonographic finding in equine tendons and ligaments. Vet Radiol Ultrasound. 2018. https://doi.org/10.1111/vru.12628.
  126. Olmstead ML, Hohn RB, Turner TM (1983) A five-year study of 221 total hip replacements in the dog. J Am Vet Hosp Med Assoc Schaumburg 183(2): 191-194.
  127. Ottenheijm RP, van’t Klooster IG, Starmans LM, Vanderdood K, de Bie RA, Dinant GJ, et al. Ultrasound-diagnosed disorders in shoulder patients in daily general practice: a retrospective observational study. BMC Fam Pract (2014) 15:1115.10.1186/1471-2296-15-115.
  128. Huang, N. Gebhart, E. Richelson, T.G. Brott, J.F. Meschia, A.C. Zubair Mechanism of mesenchymal stem cell-induced neuron recovery and anti-inflammation Cytotherapy, 16 (10) (2014), pp. 1336-1344.
  129. Patterson-Kane JC, Becker DL, Rich T. The pathogenesis of tendon microdamage in athletes: the horse as a natural model for basic cellular research. J Comp Pathol. 2012;147:227–47.
  130. Pérez-Merino EM, Usón-Casaús JM, Duque-Carrasco J, Zaragoza-Bayle C, Mariñas-Pardo L, Hermida-Prieto M, Vilafranca-Compte M, Barrera-Chacón R, Gualtieri M. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: endoscopic and histological outcomes. Vet J. 2015;206:1–23. doi: 10.1016/j.tvjl.2015.07.007.
  131. Pérez-Merino EM, Usón-Casaús JM, Zaragoza-Bayle C, et al. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes. Vet J 2015;206:385–90.
  132. Piermattei DL, Flo GL, DeCamp CE. Chapter 18 – the stifle joint. In: Piermattei DL, Flo GL, DeCamp CE, editors. Brinker, Piermattei, and Flo’s Handbook of Small Animal Orthopedics and Fracture Repair. Philadelphia, PA: Saunders; (2006). p. 562–632.
  133. Pollitt C., Collins S.N. Chronic laminitis. In: Ross M.W., Dyson S.J., editors. Diagnosis and Management of Lameness in the Horse. 2nd ed. Elsevier Saunders Health Sciences; St. Louis, MO, USA: 2010. pp. 374–377.
  134. Price RD, Das-Gupta V, Harris PA, et al. The role of allogenic fibroblasts in an acute wound healing model. Plast Reconstr Surg. 2004;113:1719–1729.
  135. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, SrivastavaD.Invivoreprogrammingofmurinecardiacfi Nature 485: 593–598, 2012.
  136. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, Pattany PM, Zambrano JP, Hu Q, McNiece I, Heldman AW, Hare JM. Allogeneic mesenchymalstemcellsrestorecardiacfunctioninchronicischemiccardiomyopathy viatrilineagedifferentiatingcapacity.ProcNatlAcadSciUSA106:14022–14027,2009.
  137. Quimby JM, Borjesson DL. Mesenchymal stem cell therapy in cats: current knowledge and potential of the future. J Feline Med Surg. 2018; 20 (3): 208-16.
  138. Quimby JM, Webb TL, Habenicht LM, Dow SW. Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies. Stem Cell Res Ther. 2013;4(2):48. Published 2013 Apr 30. doi:10.1186/scrt198.
  139. Quimby, J. M., & Borjesson, D. L. (2018). Mesenchymal stem cell therapy in cats: Current knowledge and future potential. Journal of Feline Medicine and Surgery, 20(3), 208–216. https://doi.org/10.1177/1098612X18758590.
  140. Rawson EA, Aronsohn MG, Burk RL (2005) Simultaneous bilateral femoral head and neck ostectomy for the treatment of canine hip dysplasia. J Am Anim Hosp Assoc 41(3): 166-170. 6
  141. Ross L. Acute kidney injury in dogs and cats. Veterinary Clinics of North America: J Small Anim Pract. 2011;41(1):1–14.
  142. Roush JK (2012) Surgical therapy of canine hip dysplasia. In: Tobias KM, Johnston SA, editors. Veterinary surgery small animal. St Louis (MO): Elsevier Saunders, pp. 849-864.
  143. Barabino and M. R. Dana, “Animal models of dry eye: a critical assessment of opportunities and limitations,” Investigative Ophthalmology and Visual Science, vol. 45, no. 6, pp. 1641–1646, 2004.
  144. Salomone F, Barbagallo I, Puzzo L, Piazza C, Li VG. Efficacy of adipose tissue-mesenchymal stem cell transplantation in rats with acetaminophen liver injury. Stem Cell Res. 2013;11:1037–1044. doi: 10.1016/j.scr.2013.07.003.
  145. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346(5):305–310.
  146. Schneider M, Angele P, Jarvinen TAH, Docheva D. Rescue plan for Achilles: therapeutics steering the fate and functions of stem cells in tendon wound healing. Adv Drug Deliv Rev. 2018;129:352–75.
  147. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: Definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004;114(1):5.
  148. Shin TH, Kim HS, Choi SW, et al. Mesenchymal stem cell therapy for inflammatory skin diseases: clinical potential and mode of action. Int J Mol Sci 2017;18:244.
  149. Simpson KW, Jergens AE. Pitfalls and Progress in the diagnosis and Management of Canine Inflammatory Bowel Disease. Vet Clin North Am - Small Anim Pract. 2011;41(2):381–398. doi: 10.1016/j.cvsm.2011.02.003.
  150. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341:738–746. 164
  151. Smith R K, Werling N J, Dakin S G, et al. 2013. Beneficial effects of autologous bone marrow- derived mesenchymal stem cells in naturally occurring tendinopathy[J]. PLoSOne, 25: 8(9): e75697.
  152. SongK,NamYJ,LuoX,QiX,TanW,HuangGN,AcharyaA,SmithCL,TallquistMD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN. Heart repair by reprogramming nonmyocytes with cardiac transcription factors. Nature 485: 599–604, 2012.
  153. Spaas JH, Broeckx SY, Chiers K, Ferguson SJ, Casarosa M, Van Bruaene N, Forsyth R, Duchateau L, Franco-Obregón A and Wuertz-Kozak K. (2015). Chondrogenic priming at reduced cell density enhances cartilage adhesion of equine allogeneic MSCs—a loading sensitive phenomenon in an organ culture study with 180 explants. Cell Physiol Biochem 37:651–665.
  154. Spaas JH, De Schauwer C, Cornillie P, Meyer E, Van Soom A and Van de Walle GR. (2013). Culture and characterisation of equine peripheral blood mesenchymal stromal cells. Vet J 195:107–113.
  155. Spees JL, Lee RH and Gregory CA. (2016). Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther 7:125.
  156. Steelman S.M., Johnson D., Wagner B., Stokes A., Chowdhary B.P. Cellular and humoral immunity in chronic equine laminitis. Vet. Immunol. Immunopathol. 2013;153:217–226. doi: 10.1016/j.vetimm.2013.03.001.
  157. Stewart A.J., Pettigrew A., Cochran A.M., Belknap J.K. Indices of inflammation in the lung and liver in the early stages of the black walnut extract model of equine laminitis. Vet. Immunol. Immunopathol. 2009;129:254–260. doi: 10.1016/j.vetimm.2008.11.001.
  158. Sutton S, Clutterbuck A, Harris P, Gent T, Freeman S, Foster N, Barrett-Jolley R and Mobasheri A. (2009). The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet J 179:10–24.
  159. Syrcle J (2017) Hip Dysplasia: Clinical Signs and Physical Examination Findings. Vet Clin North Am Small Anim Pract 47(4): 769-775.
  160. Tautenhahn HM, Bruckner S, Baumann S, Winkler S, Otto W, von Bergen M, et al. Attenuation of postoperative acute liver failure by mesenchymal stem cell treatment due to metabolic implications. Ann Surg. 2016;263:546–556. doi: 10.1097/SLA.0000000000001155.
  161. Tempfer H, Traweger A. Tendon vasculature in health and disease. Front Physiol. 2015;6:330.
  162. TL, Webb, CB. Stem cell therapy in cats with chronic enteropathy: a proof-of-concept study. J Feline Med Surg 2015; 17: 901–908.
  163. Tomlinson J, McLAughlin R (1996) Medically managing canine hip dysplasia. Vet Med 9(1) 8-53.
  164. Trzil, JE, Masseau, I, Webb, TL. Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma. Clin Exp Allergy 2014; 44:1546–1557.
  165. Vaden SL, Levine J, Breitschwerdt EB. A retrospective case-control of acute renal failure in 99 dogs. J Vet Intern Med. 1997;11(2):58–64.
  166. Van Weeren PR and de Grauw JC. (2010). Pain in osteoarthritis. Vet Clin North Am Equine Pract 26:619–642.
  167. Villatoro AJ, Fernández V, Claros S, et al. Regenerative therapies in dry eye disease: from growth factors to cell therapy. Int J Mol Sci 2017;18:2264.
  168. Villatoro AJ, Fernández V, Claros S, Rico-Llanos GA, Becerra J, Andrades JA. Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model. Biomed Res Int. 2015;2015:527926. doi:10.1155/2015/527926.
  169. Villatoro, AJ., Hermida-Prieto, M., Fernández, V., Fariñas, F., Alcoholado, C., Rodríguez-García, MI., Mariñas-Pardo, L., Becerra, J.(2018) Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safetyVeterinary Record 183, 654.
  170. Walden G, Liao X, Donell S, Raxworthy MJ, Riley GP, Saeed A. A clinical, biological, and biomaterials perspective into tendon injuries and regeneration. Tissue Eng Part B Rev. 2017;23:44–58.
  171. Wang D, Niu L, Feng X, Yuan X, Zhao S, Zhang H, et al. Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study. Clin Exp Med. 2016.
  172. Wang J, Cen P, Chen J, Fan L, Li J, Cao H, et al. Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure. Stem Cell Res Ther. 2017;8:137. doi: 10.1186/s13287-017-0576-4.
  173. Wang YH, Wu DB, Chen B, Chen EQ, Tang H. Progress in mesenchymal stem cell-based therapy for acute liver failure. Stem Cell Res Ther. 2018;9(1):227. Published 2018 Aug 24. doi:10.1186/s13287-018-0972-4.
  174. Webb, TL, Webb, CB. Stem cell therapy in cats with chronic enteropathy: a proof-of-concept study. J Feline Med Surg 2015; 17: 901–908.
  175. Wei A, Shen B, Williams L, Diwan A. Mesenchymal stem cells: potential application in intervertebral disc regeneration. Transl Pediatr. 2014;3(2):71–90. doi:10.3978/j.issn.2224-4336.2014.03.05. 13
  176. Wilke MM, Nydam DV and Nixon AJ. (2007). Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 25:913–925.
  177. Wilke MM, Nydam DV and Nixon AJ. (2007). Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 25:913–925.
  178. Winer, JN, Arzi, B, Verstraete, FJ. Therapeutic management of feline chronic gingivostomati-tis: a systematic review of the literature. Front Vet Sci 2016; 3: 54.
  179. Wu Y, Chen L, Scott PG, et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007;25:2648–2659.
  180. Q. Zhou and R. L. Wei, “Topical cyclosporine a in the treatment of dry eye: a systematic review and meta-analysis,” Cornea, vol. 33, no. 7, pp. 760–767, 2014.
  181. Zhu, B. Zhang, H. Zhao, X. Dou, J. Bai, G. Zhang Jagged-2 enhances immunomodulatory activity in adipose derived mesenchymal stem cells Sci Rep, 5 (2015), p. 14284.
  182. Shi, J. Su, A.I. Roberts, P. Shou, A.B. Rabson, G. Ren How mesenchymal stem cells interact with tissue immune responses Trends Immunol, 33 (3) (2012), pp. 136-143.
  183. Yoshikawa T, Mitsuno H, Nonaka I, et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg. 2008;121:860–877.
  184. Yuan S, Jiang T, Sun L, Zheng R, Ahat N, Zhang Y. The role of bone marrow mesenchymal stem cells in the treatment of acute liver failure. Biomed Res Int. 2013;2013:251846.
  185. Zajic LB, Webb TL, Webb P, Coy JW, Dow SW, Quimby JM. Comparison of proliferative and immunomodulatory potential of adipose-derived mesenchymal stem cells from young and geriatric cats. J Feline Med Surg. 2016.
  186. Zang, Li & Hao, Haojie & Liu, Jiejie & Li, Yijun & Han, Weidong & Mu, Yi-Ming. (2017). Mesenchymal stem cell therapy in type 2 diabetes mellitus. Diabetology & Metabolic Syndrome. 9. 10.1186/s13098-017-0233-1.
  187. Zeckser J, Wolff M, Tucker J, Goodwin J. Multipotent Mesenchymal Stem Cell Treatment for Discogenic Low Back Pain and Disc Degeneration. Stem Cells Int. 2016;2016:3908389. doi:10.1155/2016/3908389.
  188. Zhang X, Lin YC, Rui YF, et al. Therapeutic Roles of Tendon Stem/Progenitor Cells in Tendinopathy. Stem Cells Int. 2016; 2016:4076578. doi:10.1155/2016/4076578.
  189. Zheng S, Yang J, Yang J, Tang Y, Shao Q, Guo L, et al. Transplantation of umbilical cord mesenchymal stem cells via different routes in rats with acute liver failure. Int J Clin Exp Pathol. 2015;8:15854–15862.